Trials / Completed
CompletedNCT07027722
Clinical Practices for Treating Severe Malaria Caused by P. Falciparum
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Centre Hospitalier de Saint-Denis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study looks at how doctors in three hospitals in France treat patients with a serious form of malaria caused by Plasmodium falciparum. It focuses on cases where the level of malaria parasites in the blood is 4% or higher. The study will compare how often a type of medicine called ACT (artemisinin-based combination therapy) is used on its own instead of the usual first-choice treatment (intravenous artesunate), and whether ACT works just as well. It will also check how well patients recover, whether they have complications, and how long they stay in the hospital.
Conditions
- Malaria, Falciparum
- Plasmodium Falciparum
- Antimalarials
- Artemisinins
- Treatment Outcome
- Drug Therapy, Combination
- Retrospective Studies
- Hospitalization
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-05-31
- Completion
- 2024-05-31
- First posted
- 2025-06-18
- Last updated
- 2025-06-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07027722. Inclusion in this directory is not an endorsement.